Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Dushyant V. Sahani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8522-1018; OpenAlex author ID A5062229082, A5112787679, A5122122112. Sources: ClinicalTrials.gov.

Their work

Papers
12 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
76
Papers, trials and grants by year

2008: 1 trial · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 paper · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 12

  1. Pancreatic Cancer-Advances in the Last 50 Years. Co-author DOI 10.1002/wjs.70309↗
  2. Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline ATM Mutated Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1016/j.adro.2025.101742↗
  3. ASGE guideline on screening for pancreatic cancer in individuals with genetic susceptibility: summary and recommendations Co-author DOI 10.1016/j.gie.2021.12.001↗
  4. American Society for Gastrointestinal Endoscopy guideline on screening for pancreatic cancer in individuals with genetic susceptibility: methodology and review… Co-author DOI 10.1016/j.gie.2021.12.002↗
  5. Main Pancreatic Duct to Parenchymal Thickness Ratio at Preoperative Imaging is Associated with Overall Survival in Upfront Resected Pancreatic Cancer. Co-author DOI 10.1245/s10434-019-08040-0↗
  6. Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial. Co-author DOI 10.1245/s10434-019-07685-1↗
  7. Association Between Changes in Body Composition and Neoadjuvant Treatment for Pancreatic Cancer. Co-author DOI 10.1001/jamasurg.2018.0979↗
  8. Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma. Last author DOI 10.1007/s00261-017-1390-2↗
  9. Imaging and Screening of Pancreatic Cancer. Last author DOI 10.1016/j.rcl.2017.06.006↗
  10. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic associatio… Co-author DOI 10.1053/j.gastro.2013.11.004↗
  11. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Associatio… Co-author DOI 10.1148/radiol.13131184↗
  12. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Co-author DOI 10.1634/theoncologist.2012-0435↗

Trials 1

  1. Secretin Enhanced MRCP for Evaluation of the Known or Suspected Intraductal Papillary Mucinous Neoplasms of the Pancreas Principal investigator NCT00621556↗

Closest collaborators

The 25 strongest of 76 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eileen Mary O'Reilly · 2 shared papers, 2019–2026 · strength 0.43
  2. Richard Zheng · 1 shared paper, 2026 · strength 0.36
  3. Savio George Barreto · 1 shared paper, 2026 · strength 0.36
  4. Anirban Maitra · 1 shared paper, 2026 · strength 0.36
  5. Charles J. Yeo · 1 shared paper, 2026 · strength 0.36
  6. Charles M. Vollmer · 2 shared papers, 2022 · strength 0.24
  7. Talia Golan · 2 shared papers, 2022 · strength 0.24
  8. Audrey H. Calderwood · 2 shared papers, 2022 · strength 0.24
  9. Marcia Irene Canto · 2 shared papers, 2022 · strength 0.24
  10. Douglas L. Riegert‐Johnson · 2 shared papers, 2022 · strength 0.24
  11. Manuel M. Hidalgo · 2 shared papers, 2022 · strength 0.24
  12. Bashar J. Qumseya · 2 shared papers, 2022 · strength 0.24
  13. Nirav C Thosani · 2 shared papers, 2022 · strength 0.24
  14. Elena M. Stoffel · 2 shared papers, 2022 · strength 0.24
  15. Mandeep Sawhney · 2 shared papers, 2022 · strength 0.24
  16. Venu Gopal Pillarisetty · 1 shared paper, 2025 · strength 0.24
  17. Jonathan G. Sham · 1 shared paper, 2025 · strength 0.24
  18. Sita Kugel · 1 shared paper, 2025 · strength 0.24
  19. Rachael Ann Safyan · 1 shared paper, 2025 · strength 0.24
  20. Elena Gabriela Chiorean · 1 shared paper, 2025 · strength 0.24
  21. Cristina Rosa Ferrone · 3 shared papers, 2013–2020 · strength 0.20
  22. Keith D. Lillemoe · 3 shared papers, 2013–2020 · strength 0.20
  23. Marta Sandini · 2 shared papers, 2018–2020 · strength 0.17
  24. Eric Peter Tamm · 3 shared papers, 2014–2019 · strength 0.14
  25. Nipun B. Merchant · 3 shared papers, 2014–2019 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.